Zoar Ltd
- Ticker
- ZOAR
- CIK
- 2078148
- Industry
- Pharmaceutical Preparations
- Formerly
- Dr Ashleys Ltd
Prospectus 9
- 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
- 424B3 Prospectus filed pursuant to Rule 424(b)(3)
- 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
- 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
- 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
- DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
- DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
- DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
- DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Other 7
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
- CERT Certification by an exchange approving securities for listing
- EFFECT Notice of Effectiveness
- F-4/A Registration statement for securities issued by foreign private issuers in certain business combination transactions
- F-4/A Registration statement for securities issued by foreign private issuers in certain business combination transactions
- F-4 Registration statement for securities issued by foreign private issuers in certain business combination transactions